Johnson & Johnson (JNJ) Applied to the European Medicines Agency to Expand AKEEGA Usage
unknown
📅 Published: 2025-07-09 05:03
📰 Source: Yahoo
📝 Words: 58
📝 Article Content
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On July 3, Janssen-Cilag, a company of Johnson & Johnson (NYSE:JNJ), reported applying to the European Medicines Agency to expand the use of AKEEGA, a drug that combines niraparib and abiraterone acetate. The new application seeks approval for […]
📄 Summary
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On July 3, Janssen-Cilag, a company of Johnson & Johnson (NYSE:JNJ), reported applying to the European Medicines Agency to expand the use of AKEEGA, a drug that combines niraparib and abiraterone acetate. The new application seeks approval for […]
Scraping Metadata:
Scraped At:
Unknown
Created At:
2025-07-09 07:11:42
Updated At:
2025-07-09 07:11:42
Scraping Job ID:
N/A
Stock Mentions:
JNJ - Johnson & Johnson
Relevance: N/A